Pharma-bio Serv, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OQB
Howard Spindel, a Director of Pharma-Bio Serv, Inc., reported a transaction in 42,504 shares of common stock on June 9, 2026.
OQB
Pharma-Bio Serv's Chairman, Kirk Wheeler Michel, acquired 20,000 stock options with an exercise price of $0.54, vesting in two equal installments.
OQB
Pharma-Bio Serv Director Dov Perlysky acquired 20,000 stock options with an exercise price of $0.54, vesting in two equal installments.
OQB
Pharma-Bio Serv, Inc. Director Howard Spindel was granted 20,000 stock options with an exercise price of $0.54, vesting over two years.
OQB
Pharma-Bio Serv Director Irving L Wiesen was granted 20,000 stock options with an exercise price of $0.54, vesting in two equal installments.
OQB
Kirk Wheeler, a director at Pharma-Bio Serv, acquired 20,000 stock options on January 10, 2025.
OQB
Director Dov Perlysky acquired 20,000 stock options in Pharma-Bio Serv, Inc. with a vesting schedule over two years.
OQB
Howard Spindel, a director at Pharma-Bio Serv, Inc., acquired 20,000 stock options with an exercise price of $0.49.
OQB
Director Irving L Wiesen of Pharma-Bio Serv, Inc. acquired 20,000 stock options on January 10, 2025.